Welcome to the Wu Group!

Wu Group: Innovating Vaccine Technologies for Global Health

Founded in 2019, the Wu Group at Shandong University is a vibrant research team focused on tackling significant challenges in vaccine development. Our mission is to create innovative carrier technologies, such as the bacteriophage Qβ VLP platform and glyconanoparticles, which enhance the immunogenicity of antigens. This strategy allows for rapid responses to emerging pathogens and promotes the advancement of vaccines targeting cancer and infectious diseases.